- Company Directors - M
- Malik Shahzad
Insider Trading History of Malik Shahzad
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Malik Shahzad since 2013.
The trader's CIK number is 1380178.
At the time of the last reporting, Malik Shahzad was the Director of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
Note that in the past
Malik Shahzad also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Histogen Inc. (CNAT) by Malik Shahzad
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | CNAT | 190,054 | $2,090,594 | 535 | $5,885 | 0 | $0 |
Yearly summary of insider trading at Iterum Therapeutics Plc (ITRM) by Malik Shahzad
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ITRM | 236,984 | $3,080,792 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aravive, Inc. (VSAR) by Malik Shahzad
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | VSAR | 0 | $0 | 650,000 | $11,934,654 | 0 | $0 |
2015 | VSAR | 55,000 | $948,750 | 0 | $0 | 0 | $0 |
2014 | VSAR | 60,000 | $1,260,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Agenus Inc (AGEN) by Malik Shahzad
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | AGEN | 0 | $0 | 1,107,377 | $7,871,671 | 0 | $0 |
Insider trading activities at 4 companies by Malik Shahzad:
1. Histogen Inc. (CNAT)
2. Iterum Therapeutics Plc (ITRM)
3. Aravive, Inc. (VSAR)
4. Agenus Inc (AGEN)
Table 1. Insider trading of Histogen Inc. (CNAT) by Malik Shahzad
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-07-30 | CNAT | Buy | 190,054 | 11.00 | 2,090,594 |
2013-07-30 | CNAT | Sale | 535 | 11.00 | 5,885 |
Table 2. Insider trading of Iterum Therapeutics Plc (ITRM) by Malik Shahzad
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-05-30 | ITRM | Buy | 236,984 | 13.00 | 3,080,792 |
Table 3. Insider trading of Aravive, Inc. (VSAR) by Malik Shahzad
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-03-17 | VSAR | Sale | 386,367 | 18.01 | 6,958,469 |
2017-03-16 | VSAR | Sale | 97,303 | 18.50 | 1,800,105 |
2017-03-13 | VSAR | Sale | 16,330 | 19.42 | 317,128 |
2017-03-14 | VSAR | Sale | 46,878 | 19.02 | 891,385 |
2017-03-15 | VSAR | Sale | 103,122 | 19.08 | 1,967,567 |
2015-01-22 | VSAR | Buy | 55,000 | 17.25 | 948,750 |
2014-03-26 | VSAR | Buy | 60,000 | 21.00 | 1,260,000 |
Table 4. Insider trading of Agenus Inc (AGEN) by Malik Shahzad
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-04-28 | AGEN | Sale | 700,000 | 7.16 | 5,012,700 |
2015-04-29 | AGEN | Sale | 407,377 | 7.02 | 2,858,971 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Malik Shahzad
(Director of Iterum Therapeutics Plc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.